About the Hives Session
Hives, known medically as urticaria, are an uncomfortable skin condition characterized by itchy raised areas on the surface of the skin. These areas, which are referred to as weals, usually appear reddish or purplish in color and can range in size from a few millimeters to a few centimeters. It is unclear why hives develop; however, certain triggers, such as certain medications, foods, environmental allergies, insect bites, infections, stress, and changes in temperature or humidity can cause hives to appear. Hives most commonly appear suddenly and can be itchy and uncomfortable. In most cases, hives will resolve quickly and the patient will be symptom free after a few hours. However, some cases of hives can last for longer periods of time and can be chronic in nature. In the case of chronic hives, an allergist or dermatologist should be consulted for further diagnosis and management of this condition. An allergist will conduct an assessment and may employ various tests, such as blood tests, skin biopsies, or an elimination diet, to determine the underlying cause of hives. The objective of management is to identify and avoid triggering factors that can cause hives as well as to reduce the inflammation and itching. Most mild cases of hives can be managed with over-the-counter antihistamine medications. In more severe cases, topical hormones or oral steroids may be prescribed to reduce the inflammation and itching of hives. In summary, hives are a relatively common skin condition that usually resolves quickly. In the majority of cases, over-the-counter antihistamines and avoiding potential triggers can be helpful in managing hives. In more severe cases, an allergist or dermatologist should be consulted for further evaluation and treatment.
Featured Speakers — Hives 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Hives Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Hives Conference 2027
Present Your Research
Oral and poster slots for original Hives work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Hives research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Hives track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Hives Conference 2027 — FAQs
What is the Hives track at IDC 2027?
The Hives track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Hives. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Hives sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Hives are all welcome — whether presenting or attending.
Can I present my research in the Hives track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Hives sessions?
Yes. IDC 2027 is a hybrid conference — attend the Hives track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

